JP Morgan Chase
TNDM icon

JP Morgan Chase’s Tandem Diabetes Care TNDM Stock Holding History

JP Morgan Chase’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-110,000
Closed -$6.99M – 6015
2019
Q1 		$6.99M Sell
110,000
-61,000
-36% -$3.2M ﹤0.01% 2333
2018
Q4 		$6.49M Buy
171,000
+50,000
+41% +$1.77M ﹤0.01% 2362
2018
Q3 		$5.18M Buy
+121,000
New +$4.23M ﹤0.01% 2717

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase's TNDM Position: Q1 2026 in Review

JP Morgan Chase increased its Tandem Diabetes Care (TNDM) stake by 2.4% in Q1 2026, buying an estimated $177K and bringing the position to 349,792 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

JP Morgan Chase first reported a position in TNDM in Q4 2013 and has held it in 40 quarters since. The position peaked at $30.8M in Q4 2013. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • JP Morgan Chase held 349,792 shares of Tandem Diabetes Care worth $6.85M as of Q1 2026.
  • JP Morgan Chase bought 8,161 Tandem Diabetes Care shares in Q1 2026, an estimated $177K.
  • Tandem Diabetes Care made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3030 holding.
  • JP Morgan Chase first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 40 quarters since.
  • JP Morgan Chase's Tandem Diabetes Care position peaked at $30.8M in Q4 2013.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.